Aesica Appoints Chris Gowland as Chief Operating Officer

Jul 29, 2013
By PharmTech Editors

Aesica, a global contract development and manufacturing organization (CDMO), announced that it has appointed Chris Gowland as Chief Operating Officer. This new position was created to further enhance the company’s operational performance in APIs and formulated product manufacturing services.

As COO, Gowland has overall responsibility for all operating strategy, which includes setting of operational standards and driving continuous improvement across the company’s manufacturing capabilities in API and formulated products.

He will also be responsible for the management of capital expenditure, procurement of materials and services, managing the supply chain, and overseeing capacity expansion across the group to ensure that Aesica meets full customer demand whilst delivering maximum service value.

Gowland is now in charge of the operational performance and general management of all Aesica manufacturing sites including Queenborough and Cramlington in the UK, Monheim and Zwickau in Germany, and Pianezza in Italy.